Copioous Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-04-2024
- Paid Up Capital ₹ 0.10 M
as on 02-04-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2017
- Revenue %
(FY 2017)
- Profit 103.81%
(FY 2017)
- Ebitda 98.26%
(FY 2017)
- Net Worth 116.33%
(FY 2017)
- Total Assets 66.91%
(FY 2017)
About Copioous Biotech
- CIN/LLPIN
U01403PN2014PTC152080
- Company No.
152080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2014
- Date of AGM
21 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Copioous Biotech Private Limited offer?
Copioous Biotech Private Limited offers a wide range of products and services, including Fertilizer, Organic Fertilizers and Manure, Plant Growth Promoters, Flowering Stimulant, Insecticides, Biopesticides, Micronutrient, Fresh Fruits, Sugarcane, Insecticides and Pesticides.
Who are the key members and board of directors at Copioous Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniket Nikam  | Director | 18-May-2017 | Current |
| Amol Nikam | Director | 18-May-2017 | Current |
Financial Performance of Copioous Biotech.
Copioous Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 103.81% increase in profit. The company's net worth Soared by an impressive increase of 116.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Copioous Biotech?
In 2017, Copioous Biotech had a promoter holding of 67.00% and a public holding of 33.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Copioous Biotech?
Unlock and access historical data on people associated with Copioous Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Copioous Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Copioous Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
